Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype
Jian Teng(Northeast Agricultural University), Bakhos A. Tannous(Massachusetts General Hospital), Pieter Wesseling(Radboud University Nijmegen), David P. Noske(Amsterdam University Medical Centers), Seyedali Hejazi(Harvard University), Lotte Hiddingh, Tracy T. Batchelor(Brigham and Women's Hospital), Litia Carvalho(Harvard University), Marco Barazas(Massachusetts General Hospital), Thomas Würdinger(Amsterdam University Medical Centers), Hiroaki Wakimoto(Harvard University), Marie Tannous(University of Notre Dame), Mark C. de Gooijer(Manchester Academic Health Science Centre)
Cited by 38
Related Papers
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
|The Journal of Experimental Medicine|2007|2.3k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
<scp>WHO</scp> 2016 Classification of gliomas
|Neuropathology and Applied Neurobiology|2017|817
Codon-Optimized Gaussia Luciferase cDNA for Mammalian Gene Expression in Culture and in Vivo
|Molecular Therapy|2004|692